Xue, Ting
Wen, Junping
Wan, Qin
Qin, Guijun
Yan, Li
Wang, Guixia
Qin, Yingfen
Luo, Zuojie
Tang, Xulei
Huo, Yanan
Hu, Ruying
Ye, Zhen
Shi, Lixin
Gao, Zhengnan
Su, Qing
Mu, Yiming
Zhao, Jiajun
Chen, Lulu
Zeng, Tianshu
Yu, Xuefeng
Li, Qiang
Shen, Feixia
Chen, Li
Zhang, Yinfei
Wang, Youmin
Deng, Huacong
Liu, Chao
Wu, Shengli
Yang, Tao
Li, Mian
Xu, Yu
Xu, Min
Wang, Tiange
Zhao, Zhiyun
Lu, Jieli
Bi, Yufang
Wang, Weiqing
Chen, Gang
Ning, Guang
Funding for this research was provided by:
Ministry of Science and Technology of the People's Republic of China (2016YFC1305600)
Chinese Medical Association Foundation and Chinese Endocrine Society (12020240314)
National Key New Drug Creation and Manufacturing Program, Ministry of Science and Technology (2012ZX09303006-001)
Ministry of Science and Technology of the People’s Republic of China (2017YFC1310700, 2016YFC1305202, 2016YFC1304904, 2018YFC1311705, 2018YFC1311800)
the National Key Research and Development Program of China (2016YFC0901203)
Article History
Received: 3 April 2021
Accepted: 22 October 2021
First Online: 10 January 2022
Declarations
:
: The authors declare that they have no conflict of interest.
: All the participants provided consent to publish their data.
: All the participants provided written informed consent.
: The present study was approved by the Medical Ethics Committee of Ruijin Hospital, Shanghai Jiaotong University (approval number: 2011-14).